Schedule 1 Status Hurts Patients Like My Dad
Written By Melanie Rizzo
At first, my dad was wholly against trying any cannabis products. However, his pain continued, as did his refusal to take any narcotic pain relievers. He started low and slow and worked his way up to a full 10mg. His mood lifted, and best of all, he was eating and sleeping soundly.
This progress came to a screeching halt when he was hospitalized for the treatment of his leukemia. A broken, overregulated system prevents patients from receiving their medical cannabis as part of their treatment regimen at most hospitals. Doctors can be prosecuted for prescribing cannabis to their patients because of the plant’s Schedule 1 status.
The possibility for cannabis to aid those suffering from a multitude of ills is still not fully understood, but when our loved ones are benefiting from the use of a harmless, natural herb like cannabis, it’s nearly unfathomable to believe that this plant has been cursed by our government for nearly 100 years.
How on earth is it possible that we regularly ingest toxic substances in our food, in our water, and in our pharmaceuticals, but a friendly green plant is vilified? It makes you wonder – how many nefarious things are going on behind the scenes, unbeknownst to the majority of us?
Cannabis Advocates and Professionals react to President Biden’s Statements Regarding Federal Marijuana Reform
Written By Bri Smith
The dust is settling from the news of last week’s announcement from President Biden regarding federal marijuana reform. For many Americans - especially cannabis advocates - it was a historic moment. However, his announcement fell short of what so many felt could have been truly beneficial for so many Americans still serving unfair sentences for nonviolent cannabis charges.
As could be expected, cannabis industry professionals and advocates had a lot to say about the statements. Some celebrated the effort, while others met it with harsh criticism for not being impactful enough. We’ve collected the statements and reactions, ranging from joy to frustration, of 30 cannabis industry professionals.